| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Department of Surgery (S.P., J.-H.Y., J.M.M.-M., Z.A.K., S.L., J.B.), Vascular Biology Program, Childrens Hospital Boston and Harvard Medical School; and Department of Pathology (E.A., F.J.S.), Brigham and Womens Hospital and Harvard Medical School, Boston, Mass. Current address for S.P.: Division of Rheumatology, Immunology, and Allergy, Brigham and Womens Hospital, Boston, Mass. Current address for E.A.: Center for Molecular Imaging Research, Massachusetts General Hospital, Charlestown. Current address for S.L.: Institute for Child Health and Great Ormond Street Hospital for Children, University College London, UK.
Correspondence to Joyce Bischoff, PhD, Childrens Hospital Boston, 300 Longwood Ave, Boston, MA 02115. E-mail joyce.bischoff{at}childrens.harvard.edu
In situ analysis of fetal semilunar valve leaflets has revealed cells coexpressing endothelial and mesenchymal markers along the endothelium, with diminished frequency seen in adult valves. To determine whether such cells are progenitor cells, we isolated clonal populations from human pulmonary valves. The clones expressed endothelial markers but showed potential to further differentiate into endothelium in response to vascular endothelial growth factor (VEGF)-A. When exposed to transforming growth factor (TGF)-ß2, individual clones adopted a mesenchymal phenotype to varying degrees and expressed markers of endothelial to mesenchymal transformation (EMT). Both VEGF- and TGFß2induced phenotypic changes were partially reversible, indicating the plasticity of these cells. When challenged with VEGF or TGFß2, a hierarchy of endothelial/mesenchymal potential could be seen among the clonal populations: cells initially closer to an endothelial phenotype showed a strong response to TGFß2 that could be inhibited by VEGF, whereas cells closer to a mesenchymal phenotype responded to TGFß2 but were resistant to endothelial-inducing effects of VEGF. These findings suggest the presence of bipotential valve progenitor cells with ability to differentiate into either endothelial or interstitial cells of the valve leaflet. Understanding the differentiation potential and function of these cells may be important for understanding heart valve disease and may also be applied to current paradigms for creating tissue-engineered heart valves.
Key Words: cell culture endothelial cell differentiation endothelial cells heart valves progenitor cells transdifferentiation vascular endothelial growth factor vascular endothelium
This article has been cited by other articles:
![]() |
M. D. Combs and K. E. Yutzey Heart Valve Development: Regulatory Networks in Development and Disease Circ. Res., August 28, 2009; 105(5): 408 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Dal-Bianco, E. Aikawa, J. Bischoff, J. L. Guerrero, M. D. Handschumacher, S. Sullivan, B. Johnson, J. S. Titus, Y. Iwamoto, J. Wylie-Sears, et al. Active Adaptation of the Tethered Mitral Valve: Insights Into a Compensatory Mechanism for Functional Mitral Regurgitation Circulation, July 28, 2009; 120(4): 334 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chaput, M. D. Handschumacher, F. Tournoux, L. Hua, J. L. Guerrero, G. J. Vlahakes, and R. A. Levine Mitral Leaflet Adaptation to Ventricular Remodeling: Occurrence and Adequacy in Patients With Functional Mitral Regurgitation Circulation, August 19, 2008; 118(8): 845 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Liu, V. R. Joag, and A. I. Gotlieb The Emerging Role of Valve Interstitial Cell Phenotypes in Regulating Heart Valve Pathobiology Am. J. Pathol., November 1, 2007; 171(5): 1407 - 1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Sales, G. C. Engelmayr Jr, J. A. Johnson Jr, J. Gao, Y. Wang, M. S. Sacks, and J. E. Mayer Jr Protein Precoating of Elastomeric Tissue-Engineering Scaffolds Increased Cellularity, Enhanced Extracellular Matrix Protein Production, and Differentially Regulated the Phenotypes of Circulating Endothelial Progenitor Cells Circulation, September 11, 2007; 116(11_suppl): I-55 - I-63. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Yana, H. Sagara, S. Takaki, K. Takatsu, K. Nakamura, K. Nakao, M. Katsuki, S.-i. Taniguchi, T. Aoki, H. Sato, et al. Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells J. Cell Sci., May 1, 2007; 120(9): 1607 - 1614. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |